Evidence map›Paper›PMID 31059001›Full record

ArticleInternational journal of molecular medicine2019

MicroRNA‑199a‑5p suppresses migration and invasion in oral squamous cell carcinoma through inhibiting the EMT‑related transcription factor SOX4.

Dongyi Wei, Weixin Wang, Baohong Shen, Yanjun Zhou, Xiaodong Yang, Guangjian Lu, Jianbin Yang, Yuebao Shao

Open access · hybridAbstract read
In one paragraph

Article in International journal of molecular medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Identification ofGenes · 2021
    Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. MicroRNAs as Modulators of Oral Tumorigenesis-A Focused Review.International journal of molecular sciences · 2021
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Dongyi WeiDepartment of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan 453100, P.R. China.
Weixin WangDepartment of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan 453100, P.R. China.
Baohong ShenDepartment of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan 453100, P.R. China.
Yanjun ZhouClinical Laboratory, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan 453100, P.R. China.
Xiaodong YangClinical Laboratory, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan 453100, P.R. China.
Guangjian LuClinical Laboratory, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan 453100, P.R. China.
Jianbin YangDepartment of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan 453100, P.R. China.
Yuebao ShaoDepartment of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan 453100, P.R. China.
First Affiliated Hospital of Xinxiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRs) are small, non‑coding RNAs that can act as oncogenes or tumor suppressor genes in human cancer. Recent studies have revealed that miR‑199a‑5p is abnormally expressed in various types of human cancer; however, the potential role of miR‑199a‑5p in oral squamous cell carcinoma (OSCC) remains elusive. The present study investigated the role of miR‑199a‑5p in OSCC cells and explored the potential molecular mechanism. Reverse transcription‑quantitative polymerase chain reaction was used to measure miR‑199a‑5p expression in OSCC tissues and adjacent normal oral epithelial tissues. Cell invasion and migration were evaluated using Transwell invasion and wound‑healing assays in OSCC cells post‑transfection with miR‑199a‑5p mimics or negative control mimics. In addition, a luciferase reporter assay was conducted to identify the target gene of miR‑199a‑5p in OSCC cells. The results demonstrated that miR‑199a‑5p expression was significantly downregulated in OSCC tissues and cell lines, and was associated with tumor progression in OSCC. Furthermore, overexpression of miR‑199a‑5p inhibited cell invasion and migration, and blocked the epithelial‑mesenchymal transition (EMT) cascade. Notably, the results revealed that the EMT‑related transcription factor SRY‑box 4 (SOX4) was a direct target gene of miR‑199a‑5p, as determined by the direct binding of miR‑199a‑5p with the 3'‑untranslated region of SOX4. In addition, knockdown of SOX4 by small interfering RNA‑SOX4 suppressed proliferation, migration and invasion of OSCC cells. Conversely, overexpression of SOX4 rescued the suppressive effects of miR‑199a‑5p on cell migration and invasion. Collectively, these data indicated that miR‑199a‑5p may inhibit the migration and invasion of OSCC cells via targeting the EMT‑related transcription factor SOX4, thus suggesting that miR‑199a‑5p may serve as a prognostic biomarker and therapeutic target in the treatment of OSCC.

Indexed as

Cell MovementEpithelial-Mesenchymal TransitionAdultAgedBiomarkers, TumorCarcinoma, Squamous CellFemaleHumansMaleMicroRNAsMiddle AgedMouth NeoplasmsNeoplasm InvasivenessNeoplasm ProteinsRNA, NeoplasmSOXC Transcription FactorsBiomarkers, TumorMicroRNAsmirn199 microRNA, humanNeoplasm ProteinsRNA, NeoplasmSOX4 protein, humanSOXC Transcription Factors

Identifiers

PMID31059001
PMCPMC6559314
OpenAlexW2942203709

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.